|
Name |
Tetracontane
|
Molecular Formula | C40H82 | |
IUPAC Name* |
tetracontane
|
|
SMILES |
CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
|
|
InChI |
InChI=1S/C40H82/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-29-31-33-35-37-39-40-38-36-34-32-30-28-26-24-22-20-18-16-14-12-10-8-6-4-2/h3-40H2,1-2H3
|
|
InChIKey |
KUPLEGDPSCCPJI-UHFFFAOYSA-N
|
|
Synonyms |
TETRACONTANE; n-Tetracontane; 4181-95-7; I79S9IXB9Y; Tetracontane, analytical standard; UNII-I79S9IXB9Y; EINECS 224-055-7; AI3-36490; DTXSID2063341; Tetracontane, >=95.0% (GC); ZINC6921185; (4-PHENOXYPHENOXY)ACETICACID; MFCD00015267; LS-15432; FT-0767531; T72448; Q151239; C4F1723F-8A7B-4248-A951-73F06DE9834E
|
|
CAS | 4181-95-7 | |
PubChem CID | 20149 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 563.1 | ALogp: | 21.3 |
HBD: | 0 | HBA: | 0 |
Rotatable Bonds: | 37 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 0.0 | Aromatic Rings: | 0 |
Heavy Atoms: | 40 | QED Weighted: | 0.052 |
Caco-2 Permeability: | -5.809 | MDCK Permeability: | 0.00000049 |
Pgp-inhibitor: | 0 | Pgp-substrate: | 0 |
Human Intestinal Absorption (HIA): | 0.005 | 20% Bioavailability (F20%): | 0.014 |
30% Bioavailability (F30%): | 1 |
Blood-Brain-Barrier Penetration (BBB): | 0 | Plasma Protein Binding (PPB): | 108.19% |
Volume Distribution (VD): | 6.871 | Fu: | 0.32% |
CYP1A2-inhibitor: | 0.008 | CYP1A2-substrate: | 0.084 |
CYP2C19-inhibitor: | 0.054 | CYP2C19-substrate: | 0.043 |
CYP2C9-inhibitor: | 0.002 | CYP2C9-substrate: | 0.989 |
CYP2D6-inhibitor: | 0.003 | CYP2D6-substrate: | 0.004 |
CYP3A4-inhibitor: | 0.062 | CYP3A4-substrate: | 0.003 |
Clearance (CL): | 3.961 | Half-life (T1/2): | 0.001 |
hERG Blockers: | 0.58 | Human Hepatotoxicity (H-HT): | 0.002 |
Drug-inuced Liver Injury (DILI): | 0.575 | AMES Toxicity: | 0.011 |
Rat Oral Acute Toxicity: | 0.005 | Maximum Recommended Daily Dose: | 0.077 |
Skin Sensitization: | 0.991 | Carcinogencity: | 0.006 |
Eye Corrosion: | 0.998 | Eye Irritation: | 0.92 |
Respiratory Toxicity: | 0.076 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000559 | 0.908 | D00AOJ | 0.504 | ||||
ENC000438 | 0.873 | D00STJ | 0.349 | ||||
ENC001204 | 0.870 | D01NTX | 0.337 | ||||
ENC000576 | 0.847 | D0Z1QC | 0.333 | ||||
ENC000381 | 0.797 | D00FGR | 0.322 | ||||
ENC000437 | 0.771 | D07ILQ | 0.319 | ||||
ENC003062 | 0.759 | D06KDP | 0.317 | ||||
ENC000443 | 0.746 | D0Z5SM | 0.284 | ||||
ENC001153 | 0.738 | D05ZPL | 0.269 | ||||
ENC000436 | 0.720 | D0T9TJ | 0.263 |